UNITED STATES SECURITIES AND EXCHANGE COMMISSION

~~SECURITIES~~Washington, ~~AND~~DC ~~EXCHANGE COMMISSION~~20549

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

~~PURSUANT~~Date TOof ~~SECTION~~Report 13(Date ORof ~~15(d~~earliest event reported) January OF15, ~~THE~~2015

SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): December 15, 2014

CANNLABS, INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada	~~333-155318~~	20333-~~5337455~~155318	20-5337455
(State or other Jurisdiction of Incorporation or Organization)	(Commission File Number)	(I.R.S. Employer Identification No.)
(State or Other Jurisdiction of Incorporation)		(Commission File Number)	(IRS Employer Identification No.)

3888 E. Mexico Ave., Suite 202, Denver, CO 80210 (Address of Principal Executive Offices) (Zip Code)

~~Denver~~(303) 309-0105 (Registrant’s Telephone Number, COIncluding ~~80210~~Area Code)

N/A (~~Address~~Former ofName ~~principal~~or ~~executive~~Former ~~offices)~~Address, ~~(Zip~~if ~~Code~~Changed Since Last Report)

~~(303)~~Check ~~309~~the appropriate box below if the Form 8-~~0105~~K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (~~Registrant’s~~17 ~~telephone~~CFR ~~number,~~230.425) ~~including~~☐ ~~area~~Soliciting ~~code~~material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Check~~Item ~~the~~5.02 ~~appropriate~~Departure ~~box~~of ~~below~~Directors ifor ~~the~~Certain ~~Form~~Officers; ~~8-K~~Election ~~filing~~of isDirectors; ~~intended~~Appointment ~~to simultaneously satisfy the filing obligation~~ of ~~the~~Certain ~~registrant~~Officers; ~~under~~Compensatory ~~any~~Arrangements of ~~the~~Certain ~~following provisions (see General Instruction A.2. below):~~Officers

~~o Written~~On ~~communications~~January ~~pursuant~~15, 2015, Steve Kilts, Chief Technology Officer and Director of CannLabs, Inc. (the “Company”), provided notice of his decision to resign ~~Rule~~from ~~425~~his ~~under~~position of Chief Technology Officer and as a member of the ~~Securities~~Board ~~Act~~of ~~(17~~Directors ~~CFR~~of ~~230~~the Company.~~425)~~

~~¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)~~Signatures

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 Regulation FD Disclosure.

On December 15, 2014, CannLabs, Inc. (the “Company”) hosted a corporate update conference call and webcast to provide investors with an update on recent corporate and business developments. A copy of the presentation utilized on the conference call and webcast is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The Company does not undertake to update this presentation.

The information contained in this Item 7.01 of this Current Report on Form 8-K and in the accompanying exhibit incorporated by reference herein shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. This information, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.	Description of Exhibit
99.1	Investor Presentation of CannLabs, Inc. dated December 15, 2014

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CannLabs, Inc.
Date: December 15, 2014	By:	/s/ Scott McPherson
Date: January 22, 2015	By:	/s/ Mark Mirken
		Scott McPherson
		Mark MirkenChief Executive Officer
		Chief Financial Officer

Filing Compare · CannLabs, Inc.